Shawn Branning

Shawn Branning currently serves as the Global Business Line Owner for Cyclodextrins & Biopharma at Ashland, focusing on strategy repositioning to enhance growth in specialty chemical and excipient portfolios. Simultaneously, Shawn holds the role of Owner and Senior Strategic Advisor at LUMIPHARMA and previously was the Global Product Management Director at ILC Dover, where leadership encompassed global product management for biopharmaceuticals and medical devices. Previous experience at IFF involved significant roles such as Global Strategic Marketing Manager and Global Pricing and Marketing Intelligence Manager, driving growth and operational efficiency. Shawn's career began at Avantor Performance Materials as a Senior Global Product Manager. Educational credentials include an MBA in Marketing and an MS in Chemistry, both from Lehigh University.